By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015 10:31:38 AM
TxCell To Present At ROTH Capital Partners Investor Conference In U.S. 2/26/2015 10:55:24 AM
TxCell Reports Revenues For 2014 And Updates On Upcoming Milestones 2/4/2015 9:42:44 AM
TxCell Announces Its Financial Calendar For 2015 1/30/2015 9:20:17 AM
TxCell Receives EUR 1 Million Milestone Payment Regarding Ovasave® Collaboration Agreement From Trizell 1/29/2015 8:58:10 AM
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015 1:31:06 PM
TxCell To Present Its Experience With Cell Therapy At The Cell & Gene Therapy Forum 2015, Washington 1/22/2015 9:51:05 AM
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015 6:49:51 AM
TxCell Receives EU Orphan Drug Designation For Col-Treg In The Treatment Of Non-Infectious Uveitis 12/17/2014 11:01:32 AM
TxCell To Present At EU Advanced Therapies Investor Day November 13, In London, UK 11/7/2014 10:56:01 AM